Cipla reported INR4.69B in Loan Capital for its fiscal quarter ending in September of 2026.





Loan Capital Change Date
aTyr Pharma USD 2.15M 437K Jun/2026
Bio Path USD 0 0 Mar/2025
Brainstorm Cell Therapeutics USD 0 0 Mar/2025
Capricor Therapeutics USD 3.38M 0 Mar/2025
Cara Therapeutics USD 0 0 Mar/2025
Cipla INR 4.69B 874.1M Sep/2026
Dr.Reddys Laboratories INR 11.92B 284M Sep/2026
Immunic USD 0 0 Jun/2024
Minerva Neurosciences USD 0 86.58M Sep/2024
Nektar Therapeutics USD 60.27M 2.89M Mar/2026
Sangamo BioSciences USD 0 0 Jun/2022
Sun Pharmaceuticals INR 4.17B 237.8M Sep/2026
TherapeuticsMD USD 0 0 Mar/2022
UPL INR 119.29B 46.27B Sep/2026